Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Julie R. Park, MD
Seattle Children's Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Westmead Hospital
Westmead, New South Wales, Australia
- Ucsf Comprehensive Cancer Center
San Francisco, California, United States
- Children'S Memorial Hospital - Chicago
Chicago, Illinois, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Children'S Hospital and Regional Medical Center - Seattle
Seattle, Washington, United States
- Mary Bridge Children'S Hospital and Health Center - Tacoma
Tacoma, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2004
- Primary completion
- 30 Sept 2006
- Completion
- 31 Dec 2013
- Last update posted
- 13 Feb 2014
- Registered enrollment
- 31
- Registry id
- NCT00070200
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.